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Available online 10 November 2015The insulin-like growth factor binding proteins (IGFBPs) are determinants of local IGF-effects and thus have an
impact on growth and metabolism in vertebrate species. In farm animals, IGFBPs are associated with traits
such as growth rate, body composition, milk production, or fertility. It may be assumed, that selective breeding
and characteristic phenotypes of breeds are related to differential expression of IGFBPs. Therefore, the aim of
the present study was to investigate the effects of selective breeding on blood IGFBP concentrations of farm
animals. Breeds of the sheep, goat, and cattle species were investigated. IGFBP-3, -2, and -4 were analyzed
with quantitative Western ligand blotting (qWLB), enabling comprehensive monitoring of intact IGFBPs with
IGF-binding capacity. We show that in sera of all species and breeds investigated, IGFBP-3, -2, and -4 were
simultaneously detectable by qWLBanalysis. IGFBP-3 and the total amount of IGFBPswere signiﬁcantly increased
(P b 0.05) in Cameroon sheep, if compared to 3 of 4 other sheep breeds, aswell as inDwarf goats versus Toggenburg
and Boer goats (P b 0.01). IGFBP-2 was elevated in Cameroon sheep and Boer goats, if compared to other breeds of
these species (P b 0.01), respectively. Holstein Friesian dairy cows had higher levels of IGFBP-4 (P b 0.05), if com-
pared to conventional crossbreeds of beef cattle. In Dwarf goats the ratio of IGFBP-3/IGFBP-2was about 3-fold higher
than in other goat breeds (P b 0.001). The total IGFBP amount of Toggenburg goats was reduced (P b 0.05), com-
pared to the other goat breeds. In conclusion, our data indicate that common and speciﬁc features of IGFBP ﬁnger-
prints are found in different ruminant species and breeds. Our ﬁndings may introduce quantitative Western ligand
blotting as an attractive tool for biomarker development and molecular phenotyping in farm animal breeds.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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A number of traits in farm animals, such as growth performance,
metabolism, meat composition, or reproduction are associated with
changes in the GH-IGF-I axis. Insulin-like growth factor 1 (IGF-1) is a
peptide hormone with crucial impact on regulation of mammalian
growth and development [14]. Its gene expression is primarily regulat-
ed by growth hormone (GH). In serum, a high percentage of IGF-1 is
bound to IGF-binding proteins (IGFBPs), which act as important regula-
tors of IGF by prolonging the half-life, or modulating the IGF availabilityAnimal Biology, Institute of
l-Allee 2, 18196 Dummerstorf,
ﬂich).
. This is an open access article underand activity [38]. IGFBPs are a family of cysteine-rich proteins sharing
high similarity in their primary amino acid sequences. There are six
mammalian IGFBPs, designated as IGFBP-1 to -6, with the ability to
bind IGFswith a high afﬁnity [13]. In addition to IGF-dependent actions,
IGF- independent actions of IGFBPs with an impact on important biolog-
ical processes such as bone cell proliferation or angiogenesis are described
[13,23]. IGFBP expression is regulated by a number of physiological condi-
tions like nutrition, pregnancy, or exercise [27]. IGFBPs are sensitive
markers to detect changes of the GH induced growth axis [1,17]. In addi-
tion they are important biomarkers for diagnostics and treatment studies
in humans [21]. Thus, in farm animals IGFBPs have biomarker potential
for improvement of phenotype selection, husbandry conditions, and
potentially even for health monitoring or the diagnosis of diseases. Previ-
ous studies in cattle described associations of IGFBP-2 expression with
body weight, fertility, milk production, and metabolic status [2,25] or asthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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vealed speciﬁc effects of IGFBPs on growth rate, body composition, and
muscle growth [28,31]. For biomarker research in farm animals the con-
sideration of breed speciﬁc differences in IGFBP expression is very attrac-
tive, since IGFBPs particularly deﬁne local IGF-effects, e.g. in the muscle
[11]. Therefore, the aim of the present study is to investigate the effects
of selective breeding on circulating levels of IGFBP in serum of different
breeds and species of farm animals. IGFBPswere detected using quantita-
tive Western ligand blotting (qWLB). Because of the highly conserved
protein structure within mammalian IGFBPs, qWLB represents an
established method for the analysis of IGFBPs in different mammalian
species [1,17,18]. The detection with qWLB ensures, that exclusively
IGFBPs with an IGF-binding capacity are detected in contrast to antibody
based methods, which also may detect IGFBP fragments. Thus, while
immunological methods produce quantitative data on the basis of the
presence of amino acid sequences in a given sample, by WLB we get an
estimate on the binding activities of IGFBPs. Thus, immunological
methods contain structural information, whereasWLB data provide func-
tional information. WLB data even may include differential afﬁnities of
IGFBPs for their ligands, due to posttranslational modiﬁcations that po-
tentially impact on the IGF-binding afﬁnities [6]. The estimate of binding
afﬁnities derived by qWLB is quantiﬁed by use of recombinant standards
as done also by other, e.g. ELISAmethodologies. In fact, this may be a cer-
tain limitation of both methods, because posttranslational modiﬁcations
can affect binding properties of ligands and antibodies. As amore general
analytical problemofWesternblotting, IGFBPs canhave similarmolecular
weights, whichmake separation and identiﬁcation of IGFBPs difﬁcult. Be-
cause in serum or plasma IGFBP-2, -3, and -4 can clearly be distinguished,
this is not a major issue in the present study. However in other matrices
e.g. tissues, speciﬁc adaptations of the analytical systemmay be required,
in order to improve resolving performance. A signiﬁcant limitation of
WLB is due to the fact that amuch higher input ofwork is required to per-
formWestern blotting if compared to ELISA. However, it is impossible to
directly compare the cost efﬁciencies of both methods, due to the dif-
ferential content of information given by immunological versus
functional data derived by ELISA or WLB, respectively. Thus, WLB
and even more qWLB, are attractive methods to investigate IGFBP-
proﬁles in various matrices eliminating the pre-selection of distinct
IGFBPs in advance. Particularly, as a tool of comparative analysis in
different vertebrate species, WLB may help to understand mecha-
nism of phenotype expression and adaptation. Finally it is important
to note, that in many species analytical assays or speciﬁc antibodies
in order to speciﬁcally detect different IGFBPs are not available to
date, suggesting WLB as an elegant method of IGFBP-proﬁle analysis
even for translational studies.
In our study we performed a comparative analysis of the amino
acid sequence of IGFBP-2 to -4, demonstrating that there are identicalTable 1
Characteristics of breeds of sheep, goats and cattle including wither's height, body weight, mai
Breed Height (cm) Weight (kg)
Sheep
Cameroon 58–65 30–40
East Friesian 70–80 80–100
Texel 68 70–90
BH Mutton 75–80 70–90
White P. Heath 50 40–45
Goat
Toggenburg 65–75 50–60
Boer 65–75 90–100
Dwarf 40–45 25
Cattle
Beef crossbreeds 135–142 700–800
Holstein Friesian 140 600–700IGF-binding sites in different types of ruminants and human. We then
provide a quantitative comparison of IGFBP-2, -3, and -4 in serum or
plasma from 10 different ruminant breeds.
2. Methods
2.1. Animals and husbandry
Blood samples of sheep (Ovis aries), goat (Capra hircus), and cattle
(Bos taurus) were analyzed including breeds with different phenotypes,
respectively. An overview about breeds and phenotypes [29] is given in
Table 1. In the analysis, as a rule sexually mature female animals were
included. All sheep and goats were older than one year. Concerning
cattle breeds, exclusively heifers with comparable ages were chosen to
exclude the effects of lactation on energy balance in dairy cows.
We analyzed ﬁve breeds of sheep, including Texel (n = 9), White
Polled Heath (White P. Heath, n = 10), German Blackheaded Mut-
ton (BH Mutton, n = 10), East Friesian Milk sheep (East Friesian,
n = 9), and Cameroon Dwarf Blackbelly sheep (Cameroon, n = 9).
All sheep were housed on farms in North-Rhine Westphalia or
Lower Saxony, Germany, representing an extensive or semi-
extensive animal husbandry. Furthermore, we analyzed Boer goats
(n = 10), Toggenburg goats (n = 10) and West African Dwarf
goats (Dwarf goats, n = 14). Boer and Toggenburg goats were
housed on farms in Mecklenburg Western Pomerania, Germany,
with pasture feeding. Dwarf goats were bred and raised in an exper-
imental goat unit of the Leibniz Institute for Farm Animal Biology
fed ad libitum with hay and 300 g mash/animal/day (FBN). More-
over, we analyzed EDTA-plasma of cattle. The examined breeds rep-
resent the economic important types dairy and beef cattle including
Holstein Friesian (n = 12) and crossbreeds with a high proportion
of Limousin and Simmental and a minor proportion of German
Angus (n = 13). All heifers were raised on pasture on farms in
Mecklenburg Western Pomerania, Germany.
2.2. Blood collection and sampling
Blood sampling of sheep and goats, except dwarf goats, occurred
during the routine veterinary checkup for diagnostics of Caprine
Arthritis Encephalitis (CAE) virus, Maedi, or Schmallenberg virus
(SBV). Blood samples of Dwarf goats were taken from the sticking
blood in the course of in-house slaughtering in the FBN Dummerstorf.
Internal studies comparing venous and sticking blood, showed no
signiﬁcant effects of blood sampling on measured IGFBP concentra-
tion (data not shown). Blood samples of heifers were taken during a
standardized veterinary examination on pasture that was performed
to evaluate the behavioral phenotype (Landesamt für Landwirtschaft,n utilization features and time of mature [29].
Utilization features Mature
Meat production, hair sheep Early
High milk production Early
Meat production, wool, very lean body Early
Meat production, wool Early
Landscape conservation Backward
High milk production Early
Meat production Early
Meat and milk, trypanotolerant Early
Meat production Early
High milk production Early
Fig. 1.Multiple sequence alignment of the IGFBP-2 amino acid sequence from different ruminants and Homo sapiens by Clustal 2.1 analysis. The arrows indicate exon boundaries. The
IGF-binding site (BS1) is present in the carboxy-terminal domain of IGFBP-2 coded by exon 1. The second IGF-binding site (BS2) is residing the carboxy-terminal so called thyrogobulin
type 1 domain coded by exons 3 and 4 [3]. The linker domain coded by exon 2 carries a CardinWeintraub sequence (PKKLRP) in heparin binding domain 1 (HBD1). A secondHBD and the
conserved integrin binding sequence motif (IB) are found in the carboxy terminal region.
44 E. Wirthgen et al. / Growth Hormone & IGF Research 26 (2016) 42–49Lebensmittelsicherheit und Fischerei, Mecklenburg-Vorpommern,
Germany; LALLF M-V/TSD/7221.3-2.1-007/11). For analyzes of
IGFBP, serum or EDTA-plasma were taken and stored at −20 °C or
−80 °C until analysis.Fig. 2. Sequence homology of the IGFBP-2 amino acid sequence from different ruminants and H2.3. Analysis of IGFBPs by quantitative Western ligand blotting
IGFBP-3, -2, and -4 were analyzed by quantitative Western ligand
blot analysis as described previously [1,12,18]. Brieﬂy, serum/plasmaomo sapiens by Clustal 2.1 analysis (bos: Bos taurus, capra: Capra hircus, ovis: Ovis aries).
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dards (R&D Systems, Wiesbaden, Germany) in artiﬁcial serum matrix
(Biopanda, County Down, United Kingdom) were diluted 1:20 and
boiled in sample buffer (312.5 mM Tris (pH 6.8), 50% (w/v) glycerol,
5mMEDTA, 1% (w/v) SDS, and 0.02% bromophenol blue) for 5min. Pro-
teins were separated by 12% SDS-PAGE followed by the transfer onto a
polyvinylidene ﬂuoride membrane (Millipore, Bedford, USA). The
blots were blocked and then incubated with biotin labeled human
IGF-2 (1:500; BioIGF2-10; ibt-systems, Binzwangen, Germany). The
binding proteins were detected by enhanced chemiluminescenceFig. 3. Protein expression of serum IGFBPs present in sheep, goat, and cattle breeds and reco
ﬁngerprints compared to human serum (B).using Luminata™ Forte (Millipore, Bedford, USA). Bands were visual-
ized on KODAK Image Station 4000MM (Molecular Imaging Systems,
Carestream Health, Inc., New Haven, USA) and quantiﬁed using
Gelanalyzer2010a software. Signal intensities were corrected for back-
ground and quantiﬁed by using human recombinant standards as calibra-
tors on each blot (R&D Systems, Wiesbaden-Nordenstadt, Germany).
Curve ﬁtting was done by a four parametric nonlinear regression (HILL
equation) of each separate IGFBP. The calculation of the IGFBP con-
centrations in serum was done with the software GraphPad Prism6 and
corrected for dilution and volume/lane of each sample. In addition, formbinant human protein standards of IGFBP-2, -3, -4 and -5 (A) and characteristic IGFBP
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the total amount of IGFBPs (total IGFBPs) was calculated for each animal
by the addition of IGFBP-3, -2 and -4 concentrations. Under non reducing
conditions the recombinant proteins IGFBP-3 (doublet: 44/41 kDa),
IGFBP-2 (34 kDa), IGFBP-5 (30 kDa), IGFBP-1 (28 kDa), and IGFBP-4
(24 kDa) can be distinguished by speciﬁc molecular weights. IGFBP-6
was not examined. IGFBP-1 is not detectable in our samples analyzed by
qWLB. Due to low abundance, IGFBP-5 was not quantiﬁed in serum. The
identity of IGFBP-2was veriﬁed by speciﬁc antiserum as described before
[18]. Human serumwas used for interspecies comparison of IGFBPﬁnger-
prints and speciﬁc molecular weights. The analytical range, as deﬁned by
the highest and lowest concentration of recombinant standard used, was
150–15,000 ng/ml for IGFBP-2, -3 and -4, respectively. The lower limits of
quantiﬁcation were 0.25 ng for IGFBP-2 and 1 ng for IGFBP-3 and -4 [18].
Inter- and intra-assay coefﬁcients of variation (CV) were determined byFig. 4. Serum concentrations of sheep (1), goat (2), and cattle (3) of IGFBP-3 (A), IGFBP-2 (B), an
differences between breeds of each species are indicated by #P b 0.1, *P b 0.05, **P b 0.01, andmeasuring artiﬁcial serum samples spiked with low (500 ng/ml) and
high (3000 ng/ml) concentrations of IGFBP-3, -2 and -4. The intra-assay
CV (n = 9) for IGFBP-3, -2, and -4 was b15% at high and low concentra-
tions. The inter-assay CV (n = 8) for all IGFBPs was b20% at low and
b15% at high concentrations.2.4. Statistics and multiple sequence alignments
Data of goats and sheep were analyzed with One-Way Analysis of
Variance (ANOVA). Tukey–Kramer procedure was used for pair-wise
multiple comparisons of IGFBPs within one species. Data of IGFBPs in
cattle were compared with T-test. Differences were considered
signiﬁcant if P b 0.05. All statistical analyses were done with GraphPad
Prism 6. Sequence alignments were performed by Clustal 2.1 analysis.d IGFBP-4 (C). The data are presented as aligned scatter dot blot (line=mean). Signiﬁcant
***P b 0.001.
Table 2
Serum concentrations of IGFBP-3, IGFBP-2, and IGFBP-4 of breeds of sheep, goats, and
cattle. Data are presented as means ± SD. Signiﬁcant differences between breeds within
one species are indicated by different letters (P b 0.05).
Breed IGFBP-3
(μg/ml)
IGFBP-2
(μg/ml)
IGFBP-4
(μg/ml)
Sheep
Cameroon 5.5 ± 1.4a 2.4 ± 1.1a 0.7 ± 0.2
East Friesian 3.9 ± 1.1b 1.7 ± 0.7 0.8 ± 0.2
Texel 4.1 ± 1.3ab 1.6 ± 0.8 0.8 ± 0.1
BH Mutton 3.0 ± 0.7b 1.7 ± 0.5 0.8 ± 0.3
White P. Heath 3.4 ± 0.9b 1.1 ± 0.6b 0.75 ± 0.2
Goat
Toggenburg 4.2 ± 1.1a 1.6 ± 0.5a 0.6 ± 0.3
Boer 4.3 ± 0.9a 2.6 ± 0.3b 0.6 ± 0.3
Dwarf 5.9 ± 1.1b 0.9 ± 0.3c 0.5 ± 0.1
Cattle
Beef crossbreeds 3.2 ± 0.6 5.0 ± 1.5a 0.6 ± 0.15a
Holstein Friesian 3.6 ± 1.0 6.2 ± 2–0b 0.85 ± 0.3b
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3.1. Comparison of IGFBPs between ruminants and humans
IGFBP-2 amino acid sequences from cattle, goats, sheep, and humans
share identical IGF-binding sites in the amino-terminal and carboxy-
terminal regions (Fig. 1). Consensus sequences for IGF-binding are
further conserved for IGFBP-3 and -4 from ruminants and humans
(not shown). Also both heparin binding sites and the integrin binding
site present in IGFBP-2 are identical in ruminants and humans. Se-
quence similarity of IGFBP-2 between species is higher than 88% be-
tween different ruminants and humans (Fig. 2). Sequence homology
of IGFBP-2 or -4 within three different ruminants is higher than 98%.
IGFBP-4 sequence homology between humans and ruminants is higher
than 96%. Amino acid sequence homology of IGFBP-3 in ruminants and
humans ranges between 80% and 99%. After electrophoretic separation
the molecular weight pattern of intact IGFBPs of ruminant breeds is
very similar to that of human recombinant standards and human
serum sample (IGFBP-3 doublet: 44/41 kDa, IGFBP-2 34 kDa, IGFBP-5:
30 kDa, IGFBP-4: 24 kDa) (Fig. 3).
3.2. Quantitative analysis of IGFBPs in ruminants
Analysis of IGFBPs in serum from sheep, goat, and cattle breeds
revealed species- and breed-speciﬁc patterns of IGFBP-3, -2, and -4
(Fig. 4 and Table 2). In sheep, ANOVA revealed a signiﬁcant effect of
breed on serum concentrations of IGFBP-3 (F4,44 = 6.73, P b 0.001)
and IGFBP-2 (F4,42 = 3.14, P = 0.02) (Fig. 4.1) and the total IGFBPs
(F4,42 = 6.73, P b 0.001) (Table 3). IGFBP-3 concentrations of
Cameroon sheep were signiﬁcantly increased compared to serum
levels of East Friesian, Blackheaded Mutton, and White P. Heath
sheep (Fig. 4.1.A). IGFBP-2 concentrations in White P. Heath sheep
were signiﬁcantly reduced compared to Cameroon sheep (Fig. 1,
IB). There was no signiﬁcant effect of breed on serum IGFBP-4 con-
centrations (Fig. 4.1.C) and IGFBP-3/-2 ratio (Table 3).
In goats, ANOVA revealed a signiﬁcant effect of breed on serum con-
centrations of IGFBP-3 (F2,31 = 11.31, P b 0.001) and IGFBP-2 (F2,31 =
62.64, P b 0.001) (Fig. 4.2), on the ratio of IGFBP-3/-2 (F2,31 = 37.63,
P b 0.001), and the total IGFBPs (F2,31 = 4.78, P = 0.016) (Table 3).
IGFBP-3 concentrations in Dwarf goats were signiﬁcantly increased
compared to Toggenburg and Boer goats (Fig. 4.2.A). In contrast,
IGFBP-2 concentrations in dwarf goats were signiﬁcantly reduced com-
pared to Toggenburg and Boer goats. IGFBP-2 levels of Boer goats were
signiﬁcantly higher than in Toggenburg goats (Fig. 4.2.B). No signiﬁcant
effect of breed on IGFBP-4 concentrations (Fig. 4.2.C) was measured.
The ratio of IGFBP-3/-2 was signiﬁcantly increased in Dwarf goats com-
pared to the other breeds (Table 3). In Toggenburg goats, the total
IGFBPs was signiﬁcantly reduced compared to the other breeds.
T-test revealed a signiﬁcant effect of breed in IGFBP-4 serum
concentration in cattle (t21 = 2.16, P b 0.043), whereas concentrations
of IGFBP-3 and IGFBP-2 (Fig. 4.3.A/B), their ratio (Table 3), and the
total IGF-binding capacity were not signiﬁcantly affected (Table 3).
The results show that the concentrations of IGFBP-4 in Holstein
Friesian Dairy cowswere signiﬁcantly higher than in crossbred beef cattle
(Fig. 4.3.C).
4. Discussion
IGFBPs represent potent effectors of growth and metabolism and
thus may affect important traits of livestock production [24]. We there-
fore have asked, if serum proﬁles of IGFBPs may have evolved in differ-
ent breeds of ruminants with breeding-speciﬁc phenotypes. All IGFBPs
from ruminants studied, share both consensus sequences for their IGF-
binding-sites in the amino-terminal (GCGCCXXC) and in the carboxy-
terminal (CWCV) protein domains [3]. We investigated breed speciﬁc
differences in circulating levels of IGFBPs, using qWLB as a tool for thecomprehensive ﬁngerprinting of IGFBP in serum. The results indicate
that selective breeding is associated with alterations of the circulating
IGFBP protein expression. Signiﬁcant differences in IGFBP-3 expression
were detected in sheep and goats. IGFBP-3 is the predominant binding
protein in mammalian blood and is stimulated by GH. It is discussed
as a biomarker for anabolic processes including growth and carcass
traits [16,28]. Treatment of beef cattle with exogenous GH induced
IGF-1 and IGFBP-3, but decreased IGFBP-2 serum concentration [34].
In addition, GH treatment increased efﬁciency of gain/feed ratio and re-
duced gain of backfat thickness, if compared to untreated control ani-
mals [34]. In the present study Cameroon sheep had increased
concentrations of IGFBP-3 compared to East Friesian, BH Mutton, and
White P. Heath sheep. Within goats, IGFBP-3 concentrations of WA
Dwarf goats were signiﬁcantly increased compared to the other goat
breeds. Both Dwarf goats and Cameroon sheep are described as small
but fast growing breeds with early mature and a high proportion of
muscle meat [29]. Thus, lower IGFBP-3 concentrations of White P.
Heath sheep may be a result of lower growing performance or dietary
energy level [4]. Results in sheep, goats, and cattle showed signiﬁcant
breed-speciﬁc differences in IGFBP-2 expression as well. Similar to
IGFBP-3, Cameroon sheep had signiﬁcantly increased IGFBP-2 concen-
trations compared to White P. Heath sheep. In contrast, IGFBP-2 in
Dwarf goats was signiﬁcantly reduced compared to Toggenburg and
Boer goats. Studies in sheep, revealed that IGFBP-2 is associated with
glucose metabolism and insulin-sensitivity caused by interactions
with leptin [37]. Furthermore, studies in transgenic mice overexpress-
ing IGFBP-2 clearly identiﬁed a negative role of IGFBP-2 for the accretion
of muscle mass [11], but further indicated gender-speciﬁc effects of
IGFBP-2 on control of eating behavior [36]. Also in growth selected
mice IGFBP-2 was discussed as a negative effector on body weight [9].
Dietary regulation of IGFBP-2 is well established [10] and there are indi-
cations, that undernutrition and the development of a catabolic state
affects serum concentrations of IGFBP-2 also in farm animals [15]. Gen-
erally, nutritional restriction results in an increase of circulating IGFBP-2
concentrations because of the reduction in protein intake [30]. Contrary
results were reported in newborn pigs, where IGFBP-2 decreased after
fasting measured by Western ligand blotting [20]. Interestingly, simul-
taneous analyses with radioimmunoassay detected increased con-
centrations of IGFBP-2 indicating elevated proteolysis but revealing
proteolytic fragments failed [20]. These results support, that qWLB
data contain biomarker information exclusively on intact IGFBPs in con-
trast to antibody based techniques as RIA or ELISA which sometimes
measure both intact and fragmented IGFBPs. In our study the differ-
ences of IGFBP-2 concentrations between breeds may be an indicator
for alternations in energy or glucose metabolism caused by selective
breeding. However, differences in their health status or even husbandry
Table 3
Calculated ratio of IGFBP-3 to IGFBP-2 and total IGFBPs of breeds of sheep, goats, and cattle.
Data are presented as means ± SD. Signiﬁcant differences between breeds within one
species are indicated by different letters (P b 0.05).
Breed IGFBP-3/-2 ratio Total IGFBPs (μg/ml)
Sheep
Cameroon 2.34 ± 0.73 8.6 ± 2.5a
East Friesian 2.66 ± 1.76 6.2 ± 1.1b
Texel 3.10 ± 1.61 6.4 ± 1.9
BH Mutton 1.91 ± 0.62 5.2 ± 1.1b
White P. Heath 4.16 ± 2.98 5.2 ± 0.8b
Goat
Toggenburg 2.67 ± 0.69a 6.0 ± 1.3a
Boer 1.66 ± 0.46a 7.5 ± 0.85b
Dwarf 7.20 ± 2.47b 7.3 ± 1.3b
Cattle
Beef crossbreeds 0.69 ± 0.25 8.7 ± 1.8
Holstein Friesian 0.66 ± 0.40 1.1 ± 2.7
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study higher levels of antepartal IGFBP-2 serum levels in dairy cows
were indicative of ketosis [26]. In the present study, the ratio of IGFBP-
3 to IGFBP-2 was signiﬁcantly increased in Dwarf goats compared to
other goats. In humans, the ratio of IGFBP-3/-2 is discussed as a
sensitivemarker for GH induced somatic growth andmetabolic homeo-
stasis, which is decreased in critical illness or low physical performance
[32,33]. The evaluation of IGFBP-3/-2 ratio as potential biomarker for
health monitoring or physical performance in farm animals is attractive
and may also have an increased sensitivity for the detection of even
smallest differences of GH-secretion. In the present study signiﬁcant dif-
ferences in IGFBP-4 were found between Holstein Friesian and a con-
ventional beef cross. IGFBP-4 concentrations are low in serum and
inﬂuenced by vitamin D and parathyroid hormone [5]. Studies in trans-
genic mice overexpressing IGFBP-4 indicated that IGFBP-4 is a function-
al antagonist of IGF-1 action on smoothmuscle growth [35]. In addition,
IGF-independent actions of IGFBP-4, as modulation of cell proliferation
were reported [5]. To date, there is only little knowledge about associa-
tions of serum IGFBP-4 concentrations in farm animals with metabolic
traits, but there are indications that IGFBP-4 is a potential biomarker
for reproductive functions [19]. Studies in women with ovarian dys-
function indicated an association of increased serum IGFBP-4 in re-
sponse to gonadotropin treatment [39]. Furthermore, studies in cattle
postulated decreased IGFBP-4 as a marker for early pregnancy in dairy
heifers [22]. It is known, that in Holstein Friesian cows the fertility de-
clined over the past 20 years [7]. May be the negative energy metabo-
lism, as a result of the genetic improvement for milk yield, is one
reason for poor reproductive performance. In calves, increased IGFBP-
4 serum concentrations in feed restricted versus ad libitum milk fed
calves were described indicating an impact of negative energy metabo-
lism on serum IGFBP-4 expression [8]. Whether the increased IGFBP-4
concentrations in Holstein Friesian have biomarker potential for repro-
ductive performance has to be investigated in future studies.
In conclusion, our results demonstrate that expression of circulating
functional IGFBPs differ between breedswithin different Bovidae family
members indicating differences in somatotropic axis and metabolic
status. Analyzing IGFBPs by qWLB can provide complex information
on IGFBP-proﬁles and even IGFBP–ﬁngerprints and thus may serve as
a powerful tool for the development of innovative biomarkers for im-
portant traits of livestock production and for molecular phenotyping
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